TB-500 (Thymosin Beta-4)
The systemic regenerative peptide for deep tissues — ideal complement to BPC-157
Definition
TB-500 (Thymosin Beta-4 fraction 17-23) is a synthetic peptide derived from thymosin beta-4, a 44-amino-acid protein present in high concentration in platelets, inflammatory cells, and regenerating tissues. It is one of the most potent regenerative peptides known due to its capacity for systemic distribution (unlike BPC-157, which acts more locally). Its main effects are upregulation of G-actin (cytoskeleton structure), promotion of angiogenesis, immune modulation, and acceleration of deep tissue healing.
Detailed explanation
Documented mechanisms:
Angiogenesis: stimulates formation of new blood vessels via VEGF and other factors. Stem cell mobilisation: increases recruitment of progenitor cells to injury sites. Immune modulation: complex anti-inflammatory effects via cytokine modulation. Cardiac regeneration: pre-clinical studies show reduction of infarction in ischaemia models. Neural regeneration: in animal models of spinal cord and brain injury. Tissue repair: tendons, ligaments, muscle, skin.
BPC-157 + TB-500 combination: the most-used peptide 'stack' in longevity biohacking and athletes. The complementarity is elegant: - BPC-157 acts preferentially on local tissue (oral or subcutaneous near the injury) - TB-500 distributes systemically to deep tissues (subcutaneous or intramuscular)
Typical dosing: Initial loading: 2.5-5 mg subcutaneous twice weekly for 4-6 weeks. Maintenance: 2.5 mg every 2 weeks for 8-12 weeks. Acute injuries: loading protocol combined with BPC-157 250-500 mcg/day.
Safety profile: well-tolerated in clinical use, no serious adverse effects documented. Theoretical caution in active cancer or history (stimulates general cell proliferation — risk-benefit balance must be individually evaluated).
Regulatory status: not approved as a medicine in EU/USA. In Spain, obtained through compounding pharmacy with specialised medical prescription, or in clinics operating under compassionate use frameworks. As with all therapeutic peptides, demand traceability and purity certification from supplier.
Scientific sources
Interested in related treatments?
Generate My Protocol